- Trials with a EudraCT protocol (999)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (54)
999 result(s) found for: Rest.
Displaying page 1 of 50.
EudraCT Number: 2006-000697-74 | Sponsor Protocol Number: ML20115 | Start Date*: 2006-08-07 |
Sponsor Name:The BONiFIN study group | ||
Full Title: A phase II, open label study to establish the safety and efficacy of intravenous loading dose of 3 x Bondronat 6 mg in 3 consecutive days in patients with breast cancer and skeletal metastases expe... | ||
Medical condition: Treatment of pain in breast cancer patients with bone metastases | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003526-32 | Sponsor Protocol Number: EQI7-16-02 | Start Date*: 2018-08-14 |
Sponsor Name:Fidia Farmaceutici S.p.A. | ||
Full Title: Randomised, double blind, parallel-groups, non-inferiority versus Flector® and superiority versus Placebo, Phase III clinical trial with Diclofenac Sodium 140 mg medicated plaster in patients with ... | ||
Medical condition: Patients with painful and phlogistic (inflammatory response) disease due to acute traumatic events (injury/contusion) of the limbs | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) HU (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-004102-42 | Sponsor Protocol Number: EP-DICLO/2G-01-2015 | Start Date*: 2017-06-06 | |||||||||||
Sponsor Name:Epifarma S.r.l. | |||||||||||||
Full Title: Randomized, multi-center, double-blind, three-armed trial, to evaluate the non-inferiority, efficacy and safety of diclofenac2% gel (Test) versus the originator diclofenac2% gel chosen as Referenc... | |||||||||||||
Medical condition: Acute traumatic events (injury/contusion) classified from mild to moderate pain at rest to the joints, muscles, tendons and ligaments | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) LV (Completed) LT (Completed) HU (Ongoing) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001779-29 | Sponsor Protocol Number: EP-DICLO/G-01-2015 | Start Date*: 2016-12-15 |
Sponsor Name:Epifarma s.r.l. | ||
Full Title: Randomized, double-blind, parallel group, placebo-controlled, multicenter clinical trial to evaluate efficacy and safety of diclofenac 1% gel produced by Epifarma s.r.l. (Test) versus the originato... | ||
Medical condition: Patients with acute painful and flogistic (inflammatory) disease due to acute traumatic events (injury/contusion) of joints, muscles, tendons and ligaments | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) DE (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001674-25 | Sponsor Protocol Number: 1684-H-295 | Start Date*: 2012-05-25 | |||||||||||
Sponsor Name:Francisco J. González Vílchez | |||||||||||||
Full Title: Evaluation of the efficacy of sildenafil on the functional capacity of patients with heart failure with preserved ejection fraction. A randomized, double blind, parallel group and placebo-controlle... | |||||||||||||
Medical condition: Heart failure with preserved ejection fraction. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022736-37 | Sponsor Protocol Number: Z7202L02 | Start Date*: 2011-02-09 | |||||||||||
Sponsor Name:Zambon S.p.A. | |||||||||||||
Full Title: Efficacy, tolerability and safety of Z7202, a once daily Diclofenac Diethylamine (DEA) medicated plaster in comparison with Flector®, a twice daily Diclofenac Hydroxyethylpyrrolidine medicated plas... | |||||||||||||
Medical condition: Diagnosis of single localized post-traumatic painful condition | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SK (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004545-32 | Sponsor Protocol Number: DEX-TRA-04 | Start Date*: 2013-02-27 | |||||||||||
Sponsor Name:Menarini Ricerche S.p.A. | |||||||||||||
Full Title: A randomized, double-blind, placebo and active-controlled, parallel-group study to evaluate the analgesic efficacy and safety of dexketoprofen trometamol and tramadol hydrochloride oral fixed combi... | |||||||||||||
Medical condition: Treatment of moderate to severe acute pain following abdominal hysterectomy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: SK (Completed) HU (Completed) ES (Completed) LV (Completed) PL (Completed) LT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001383-10 | Sponsor Protocol Number: 57340 | Start Date*: 2016-07-04 |
Sponsor Name:Rijnstate ziekenhuis | ||
Full Title: Evaluating the effect of short term withdrawal of PPI's in patients for reducing stomach wall uptake with 99mTc Sestamibi for myocardial perfusion imaging | ||
Medical condition: The goal is to acquire knowledge about the impact of the withdrawal of PPI’s, so as to minimize disturbance of the stomach wall in myocardial perfusion imaging. The associated main question is ther... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002823-41 | Sponsor Protocol Number: AC-065B302 | Start Date*: 2019-06-03 | |||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd | |||||||||||||
Full Title: A multicenter, randomized, double-blind, placebo-controlled, parallel-group, group-sequential, adaptive, Phase 3 study with open-label extension period to assess the efficacy and safety of selexipa... | |||||||||||||
Medical condition: Chronic Thromboembolic Pulmonary Hypertension, inoperable or persistent/recurrent | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) CZ (Prematurely Ended) BE (Completed) NL (Completed) HU (Completed) AT (Completed) BG (Completed) DK (Prematurely Ended) PT (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002293-54 | Sponsor Protocol Number: Apex01version6 | Start Date*: 2007-11-29 |
Sponsor Name:University of Dundee | ||
Full Title: The APEX Trial: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients with Cardiac Syndrome X | ||
Medical condition: Patients with cardiac syndrome X (typical anginal-like chest pain and normal coronary arteriograms) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001918-98 | Sponsor Protocol Number: 31052015 | Start Date*: 2016-01-12 |
Sponsor Name:Vestre Viken HF | ||
Full Title: RATe control in Atrial Fibrillation II | ||
Medical condition: Permanent atrial fibrillation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015059-26 | Sponsor Protocol Number: 510460 | Start Date*: 2010-08-19 |
Sponsor Name:Actavis GmbH & Co. KG | ||
Full Title: Efficacy of 12 weeks oral Pentalong® on Exercise Capacity and Quality of Life in Patients With Systolic Heart Failure and Secondary Pulmonary Hypertension Short title: CAESAR Clinical efficacy ... | ||
Medical condition: Woman and men suffering from heart failure NYHA II-IV and secondary pulmonary hypertension Objectives PVR improvement after a 12 week oral Pentalong® therapy in addition to standard long-term HF... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-002580-85 | Sponsor Protocol Number: 3d | Start Date*: 2005-08-08 |
Sponsor Name:Rigshospitalet | ||
Full Title: Acute haemodynanic effects of Treatment with ACE inhibitores in patients with severe Aortic Stenosis | ||
Medical condition: Aortic valve stenosis is a reduction of the aortic valve orifice to a degree where emptying of the left ventricule is compromised. The two major causes for aortic valve stenosis is calcific valve d... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003521-34 | Sponsor Protocol Number: CHUBX2015/14 | Start Date*: 2015-10-09 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Hypertrophic CARdiomyopathy symptom release by alpha stimulant MIDOdrine | ||
Medical condition: Hypertrophic cardiomyopathy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004548-31 | Sponsor Protocol Number: DEX-TRA-05 | Start Date*: 2013-04-15 | |||||||||||
Sponsor Name:Menarini Ricerche S.p.A. | |||||||||||||
Full Title: A randomized, double-blind, placebo and active-controlled, parallel-group study to evaluate the analgesic efficacy and safety of dexketoprofen trometamol and tramadol hydrochloride oral fixed combi... | |||||||||||||
Medical condition: Treatment of moderate to severe acute pain after elective unilateral total hip arthoplasty | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) ES (Completed) HU (Completed) LV (Completed) LT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004128-38 | Sponsor Protocol Number: 123 | Start Date*: 2006-02-06 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Pregabalin for pain reduction in Critical Limb Ischemia | ||
Medical condition: Peripheral arterial disease - Critical Limb Ischemia (CLI) CLI is the end stage of peripheral arterial disease in the legs and is a onsequence of deteriorating blood flow supply to the lower limbs.... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004792-50 | Sponsor Protocol Number: C1502 | Start Date*: 2017-08-22 |
Sponsor Name:Biologische Heilmittel Heel GmbH | ||
Full Title: Multi-centre, Double-blind, Randomised, Active- and Placebo-Controlled, Confirmatory Trial to Demonstrate Efficacy and Safety of Traumed® Gel in Patients having Acute Ankle Sprain | ||
Medical condition: Acute Ankle Sprain | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-022558-18 | Sponsor Protocol Number: 2010-022558-18 | Start Date*: 2010-10-11 | ||||||||||||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | ||||||||||||||||||||||||||||
Full Title: A pilot trial with clenbuterol in spinal and bulbar muscular atrophy (SBMA). | ||||||||||||||||||||||||||||
Medical condition: spinal and bulbar muscular atrophy (SBMA) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-000549-73 | Sponsor Protocol Number: MRZ 60201-GL-3001 | Start Date*: 2008-05-15 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: A prospective, open-label, international, multicenter trial to investigate the efficacy and safety of NT 201, free of complexing proteins, in the treatment of glabellar frown lines | |||||||||||||
Medical condition: Treatment of glabellar frown lines | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-002862-15 | Sponsor Protocol Number: BupivacTons20 | Start Date*: 2021-03-03 |
Sponsor Name:Nordland Hospital. Bodø. Dep of Surgery | ||
Full Title: Can topical anaesthesia with bupivacaine reduce pain after tonsillectomy? | ||
Medical condition: Local pain after tonsillectomy, both at rest and during swallowing. Assessed by self-reporting at 1, 2, 3, 4, 5, 6 hours and 1,2,4 and 6 days after surgery. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
